Despite advancements in diabetes care, including the development of insulin analogs, continuous glucose monitoring, and automated insulin delivery systems, type 1 diabetes remains a condition that imposes significant medical, psychological, and socioeconomic burdens on affected individuals. Here, INS is linked to type 1 diabetes mellitus.